CME Relative Valuation
CME's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CME is overvalued; if below, it's undervalued.
Historical Valuation
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
0.00
P/B
Median3y
Median5y
0.00
FCF Yield
Median3y
Median5y
Competitors Valuation Multiple
The average P/S ratio for CME's competitors is 6.55, providing a benchmark for relative valuation. CME Group Inc Corp (CME) exhibits a P/S ratio of 14.57, which is 122.60% above the industry average. Given its robust revenue growth of -0.95%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
FAQ
Is CME Group Inc (CME) currently overvalued or undervalued?
What is CME Group Inc (CME) fair value?
How does CME's valuation metrics compare to the industry average?
What is the current P/B ratio for CME Group Inc (CME) as of Apr 28 2025?
What is the current FCF Yield for CME Group Inc (CME) as of Apr 28 2025?
What is the current Forward P/E ratio for CME Group Inc (CME) as of Apr 28 2025?